Global Advanced Wound Closure Market Size Report Segmented by Product (Topical Adhesives, Internal Fixation & Sealants, Sutures, Biosurgicals Devices), Application (Cardiovascular, Orthopaedic, General Surgery, Dental), End-user Analysis & Regional Forecast to 2031

Advanced wound closure describes a specific area of medical treatments that uses products and/or devices separately or in conjunction, aimed to promote wound closure and healing, lower the chance of complications, and enhance patient outcomes compared to traditional care and treatments. This category includes topical adhesives which help to close skin wounds faster, and are often used along with sutures; internal fixation adhesives to secure hernia mesh; sealants to assist in preventing internal bleeding; sutures, clips and/or clamps; and biosurgical products like hemostats, collagen membranes, and bone substitutes, that will promote tissue regeneration. These solutions are critical in surgical, chronic, and complex wound management, emphasizing minimally invasive procedures and optimized recovery.

Growth in surgical procedure volumes to propel market demand

The advanced wound closure market is significantly influenced by the rising volume of surgical procedures worldwide, which serves as a primary growth driver. With increasing global population, aging demographics, and a higher prevalence of chronic diseases, the demand for both elective and emergency surgical interventions has escalated. Surgical procedures, ranging from cardiovascular and orthopedic surgeries to general and dental surgeries, often require precise wound closure solutions to minimize complications, prevent infections, and promote faster healing. This growing need directly fuels the demand for advanced wound closure products, including sutures, clips, clamps, topical adhesives, sealants, and biosurgicals such as hemostats, collagen membranes, and bone substitutes.

Topical adhesives, for instance, are increasingly used as adjuncts to sutures in surgeries, reducing procedure time and enhancing cosmetic outcomes. Sealants and internal fixation adhesives are critical in procedures like hernia repairs, cardiovascular surgeries, and orthopedic reconstructions, where controlling internal bleeding or securing tissue and implants is essential. Similarly, specialty sutures and clips are in rising demand for cardiovascular and dental surgeries due to their precision and compatibility with delicate tissues. Biosurgical products like hemostats and bone substitutes further support surgical success by promoting clotting and tissue regeneration, addressing complex surgical scenarios and chronic wound management.

In addition, the change toward less invasive and outpatient procedures supports this growth. Advanced wound closure products encourage quicker recovery and the reduction of hospital stays, as these products relate to a worldwide movement toward reducing healthcare costs, improving patient throughput, etc. As hospitals and surgical centers increasingly implement such technologies, the market has both volume increases and value increases (given certain products are priced at a premium). Emerging economies add to market growth as improving healthcare infrastructure and increasing access to surgical procedures increases volumes in these areas. Growing awareness by healthcare practitioners regarding the benefits of advanced wound closure, such as decreased post-operative complications, scarring, and infections, is also contributing to increased use.

In conclusion, the increase in surgical procedure volumes serves as a primary catalyst to the advanced wound closure market by sustaining demand for products that provide choice, innovation, improved patient outcomes, and reduced risk to surgical care while also supporting a worldwide trend toward value-based, efficient, minimally invasive healthcare.

To learn more about this report, download the PDF brochure

Increased surgeon adoption of advanced technologies is driving the market growth

The advanced wound closure sector is rapidly expanding as surgeons are more frequently adopting advanced technologies that driving the increased demand in clinical settings. Modern surgical procedures often employ products such as topical adhesives, internal fixation adhesives, sealants, specialty sutures, clips, clamps, and biosurgery materials. By using these products, surgeons now have the ability to improve outcomes for patients, reduce complications, and increase the efficiency of procedures and/or workflows. Many surgeons are using adhesives within procedures to reduce risk of infection, improve closure speed, and improve outcomes. As they reduce risk of contamination and provide a safer alternative to traditional sutures, the use of adhesive is considered more efficient. This efficiency is especially true in specialties such as cardiovascular surgery, orthopedic surgery, and general surgery.

Hospitals play a crucial role in this trend because hospital administrators are focusing on operating room (OR) efficiencies to mitigate the high costs associated with extended OR time. By using advanced adhesives and sealants, surgeons are able to close wounds more quickly and, therefore, reduce the surgery time, reduce exposure to anesthesia, and realize better utilization of the OR space. This also enhances patient safety and OR efficiency thus promoting hospitals to support the use of advanced wound closure products.

In addition, a new generation of surgeons are being trained to use advanced adhesive products and devices. Surgical education now more often adds hands-on experience with these technologies, allowing trainees to become acquainted with these products. Thus, younger surgeons are more comfortable and confident in the use of adhesives, sealants, and other advanced closure devices, which continues to create the momentum for them to be more widely used in hospitals and surgical centers. This generational change will lead to the greater adoption of advanced wound closure products, not only in future surgical procedures but as another standard of care.

Furthermore, the new technologies associated with adhesives, sealants, and biosurgical products, or innovative formulations such as bioactive, fast-setting adhesives, or improved biocompatibility, support adoption due to their ability to address clinical issues such as infection, bleeding, and tissue regeneration. Coupled with the institutional incentives to be time and cost-effective, these changes continue to demonstrate important extensions to the market.

Rise in ambulatory surgical centers (ASC) and outpatient care fuels the growth of the market

The market for advanced wound closure is seeing strong growth due to the growth of ambulatory surgical centers (ASCs) and outpatient care facilities, which are disrupting the delivery of surgical services. The number of Medicare-Certified ASCs in US increased from 5927 in 2020 to 6394 in 2024 (Source: Ambulatory Surgery Center Association). The ASC space is expanding as procedures move out of traditional hospitals due to benefits in lower cost, flexible timing, and personalized care. Patients are continuing to choose outpatient procedures not only to reduce the length of the stay in the hospital, but also to ensure a more convenient and comfortable care delivery process. This change has a direct effect on the need for advanced wound closure products like topical adhesives, sealants, specialty sutures, and biosurgical materials, which improve the speed of wound closure, reduce complications, and also improve post-operative recovery times, which are important consideration when caring for patients in ASCs.

Payers, including the Centers for Medicare & Medicaid Services (CMS) and private insurers, are facilitating this shift by covering an increasing number of procedures delivered in ASCs based on the cost benefits of outpatient care. By incentivizing the delivery of these types of services in the ASC setting rather than a hospital, payers provided an additional impetus to achieving higher procedures volumes in an ASC which ultimately drives increased sales of advanced wound closure products. Faster, safer, more efficient closure solutions provide ASCs with a solution to better meet patient and payer expectations by reducing operative times and minimizing complications, making care delivery more efficient overall.

Moreover, ASCs and pharmacies increasingly deliver urgent care services as part of a larger trend toward convenient, greater access, and less expensive healthcare. Private equity investment in the US urgent care market is increasing rapidly, covering approximately 18% of the 14,423 urgent care centers nationwide by mid-2025. This growth, particularly at ASCs, encourages the growing use of adhesive and other fast wound closure products, as ASCs are typically value-based and focus on treatments that enable the patient to recover quickly with minimal complications for same-day discharge.

Emerging and next-generation adhesives, sealants, or minimally invasive wound closure devices fit seamlessly into the operational priorities of ASCs and urgent care centers. Products that reduce the time for procedures, reduce the risk for infection, and enhance cosmetic outcomes are the focus of a growing preference that will drive additional growth in the market. To summarize, ASCs and outpatient care are key elements of growth in the advanced wound closure market. The evolving preferences of patients and payers, changes to payer policy, as well as more equity investment in urgent care are fostering expansion and usage of effective and efficient fast wound closure solutions in outpatient settings, where there is an established market for growth.

To learn more about this report, download the PDF brochure

Product Segment Outlook

Among the advanced wound closure market, sutures, clips and clamps segment is the leading market segment by product category due to its long-standing use for almost every clinical surgical procedure including cardiovascular, orthopedic, dental surgeries and general surgery. These products are necessary, variable, trusted products for tissue approximation and are a continuous revenue source worldwide. On the other hand, Biosurgicals products including hemostats, collagen membranes, and bone substitutes is likely to be the fastest growing segment. Owing to technological innovations, increasing complex surgeries, and rising demand for enhanced tissue regeneration and bleeding control, biosurgical products are witnessing rapid adoption, particularly in minimally invasive procedures and high-risk surgical settings.

Regional Outlook: North America holds a major share in the advanced wound closure market

In the advanced wound closure market, North America is the largest regional segment because of its high surgical volumes, an established healthcare infrastructure, strong uptake of advanced technologies, and favorable reimbursement conditions. Europe is growing steadily because of advanced technology adoption for treatment of wounds, an aging population that requires more surgical procedures, and government initiatives aimed at increasing efficiency in medical care and treatment. Investments in minimally invasive intervention strategies and advanced biosurgical products also support the market growth in Europe. The Asia-Pacific (APAC) region is likely to showcase significant growth rate due to improving healthcare access, increased awareness, rise in surgical procedures, and growing hospital infrastructures in emerging countries.

Competitive Landscape Analysis

The global advanced wound closure market is marked by the presence of established and emerging market players such as Ethicon (Johnson & Johnson Surgical Technologies) (US); Medtronic plc (US); B. Braun SE (Germany); Advanced Medical Solutions Group plc (UK); Becton, Dickinson and Company (US); H.B. Fuller (US); Baxter (US); Integra LifeSciences Corporation (US); Smith+Nephew (UK); and Stryker (US); among others. Some of the key strategies adopted by market players include product innovation and development, strategic partnerships and collaborations, mergers and acquisitions, and geographic expansion.

Get a sample report for competitive landscape analysis

Report Scope

Global Advanced Wound Closure Market Segmentation

This report by Medi-Tech Insights provides the size of the global advanced wound closure market at the regional- and country-level from 2024 to 2031. The report further segments the market based on product, application, and end-user.

Market Size & Forecast (2024-2031), By Product, USD Billion

• Topical Adhesives
  • Octyl Cyanoacrylate Adhesives
  • N-Butyl Cyanoacrylate Adhesive
  • 2-Ethyl Cyanoacrylate Adhesive
  • Others
• Internal Fixation & Sealants
  • Internal Fixation Products
  • Sealants
• Sutures, Clips & Clamps
  • Sutures
    • Absorbable Sutures
    • Non-Absorbable Sutures
  • Clips & Clamps
• Biosurgical Devices
  • Hemostats
  • Collagen Membranes
  • Bone Substitutes

Market Size & Forecast (2024-2031), By Application, USD Billion

• Cardiovascular Surgery
• Orthopaedic Surgery
• General Surgery
• Dental Surgery
• Neurosurgery
• Other Applications

Market Size & Forecast (2024-2031), By End-user, USD Billion

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Other End Users

Market Size & Forecast (2024-2031), By Region, USD Billion

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa

Related Reports:

Global Collagen Membranes Market Size, Share, Growth & Trends Report Segmented by Source (Bovine, Porcine), Type (Resorbable, Non-resorbable), Application (Dental, Neurosurgery), End-user (Hospitals, ASCs) & Regional Forecast to 2031

Global Topical Adhesives Market Size & Trends Report Segmented by Product (Octyl Cyanoacrylate, N-Butyl Cyanoacrylate), Application (Orthopaedic, Paediatric, Cosmetic, Trauma, General Surgery), Wound Type (Small, Medium, Large), End User (Hospitals, ASCs) Regional Forecast to 2030

Global Biosurgery Market Size and Trends Report Segmented by Product Type (Hemostatic Agents, Adhesion Barriers, Sealants), Application (Orthopedic Surgery, Cardiovascular Surgery, General Surgery) Analysis and Regional Forecast to 2030